Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

NCT05615220 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette Disorder

Interventions

DRUG: Ecopipam Hydrochloride

Sponsor

Emalex Biosciences Inc.